[PDF] por-journal.com

[PDF][PDF] PD-1 and PD-L1 expression in rare lung tumors

M Gyulai, Z Megyesfalvi, L Reiniger… - Pathology and …, 2023 - por-journal.com
Background: Our knowledge is still limited about the characteristics and treatment of rare
lung tumors. The aim of our study was to determine programmed cell death ligand-1 (PD-L1) …
被引用次数：2 相关文章
[HTML] nih.gov

[HTML][HTML] PD-1 and PD-L1 expression in rare lung tumors

M Gyulai, Z Megyesfalvi, L Reiniger… - Pathology and …, 2023 - ncbi.nlm.nih.gov
Background: Our knowledge is still limited about the characteristics and treatment of rare
lung tumors. The aim of our study was to determine programmed cell death ligand-1 (PD-L1) …
[PDF] por-journal.com

[PDF][PDF] PD-1 and PD-L1 expression in rare lung tumors

M Gyulai, Z Megyesfalvi, L Reiniger, T Harko… - 2023 - por-journal.com
Background: Our knowledge is still limited about the characteristics and treatment of rare
lung tumors. The aim of our study was to determine programmed cell death ligand-1 (PD-L1) …

PD-1 and PD-L1 expression in rare lung tumors.

M Gyulai, Z Megyesfalvi, L Reiniger… - Pathology & …, 2023 - search.ebscohost.com
Background: Our knowledge is still limited about the characteristics and treatment of rare
lung tumors. The aim of our study was to determine programmed cell death ligand-1 (PD-L1) …

PD-1 and PD-L1 expression in rare lung tumors

M Gyulai, Z Megyesfalvi, L Reiniger… - Pathology …, 2023 - pubmed.ncbi.nlm.nih.gov
Background: Our knowledge is still limited about the characteristics and treatment of rare
lung tumors. The aim of our study was to determine programmed cell death ligand-1 (PD-L1) …

PD-1 and PD-L1 expression in rare lung tumors

M Gyulai, Z Megyesfalvi, L Reiniger… - Pathology Oncology …, 2023 - europepmc.org
Background: Our knowledge is still limited about the characteristics and treatment of rare
lung tumors. The aim of our study was to determine programmed cell death ligand-1 (PD-L1) …